Pharma co director denies stocking Remdesivir vials in Mumbai

PTI | Mumbai | Updated: 20-04-2021 16:23 IST | Created: 20-04-2021 16:23 IST
Pharma co director denies stocking Remdesivir vials in Mumbai

The Bruck Pharma director, who was questioned by Mumbai police over the company's Remdesivir stock, has denied stocking the vials in the city and claimed the consignment has been moved to a godown in Daman, a police official said on Tuesday.

Remdesivir is listed for use in serious COVID-19 patients. In view of a sudden spike in demand of the drug due to the surge in COVID-19 cases, the Centre last week banned its export till the situation improves.

The Mumbai police on Saturday questioned Rajesh Dokania, the director of the Daman-based pharmaceutical company that manufactures Remdesivir vials, following information that around 60,000 vials were going to be flown abroad by air cargo, despite a ban on the export of the drug.

During his questioning, the police sought to know the whereabouts of the drug stock, the official said.

''The pharma company director claimed the stock was moved to the firm's godown in the neighbouring Union Territory of Daman as its export was banned and denied stocking the vials in Mumbai,'' the official said.

The police are verifying the information provided by the pharma firm executive, he said.

Dokania was questioned at the BKC police station here and was later allowed to go. But, the police asked him to remain present for inquiry whenever he is called.

On learning that Dokania was being quizzed, Fadnavis and another state BJP leader Pravin Darekar had rushed to the police station on Saturday night.

They said the BJP was reaching out to pharma companies due to the shortage of Remdesivir in the state.

''It was our sincere attempt to get Remdesivar for Maharashtra,'' Fadnavis had said.

The former CM had also said permission was taken from the FDA commissioner to donate the stock of Remdesevir vials to the Maharashtra government, as the drug stocked for export cannot be diverted to the domestic market without the nod of the Drugs Controller General of India (DCGI) or the FDA.

The communication from the Food and Drug Administration (FDA) to the pharmaceutical company was not shared with the BKC police station, which was acting independently on the information available with them, a Mumbai police spokesperson had said.

The pharma company director was called for an inquiry in order to trace and seize about 60,000 vials of the key anti-viral drug based on a specific inputs, the police said.

The inquiry was necessary in light of complaints of rampant hoarding and black marketing of Remdesevir and its shortage being faced by citizens, they said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...


Latest News

MP govt plane carrying Remdesivir crash-lands in Gwalior

A Madhya Pradesh government plane carrying a stock of anti-viral drug Remdesivir crash-landed at Gwalior airport on Thursday evening following a technical snag, a senior police official said.The pilot and co-pilot suffered minor injuries, G...

Mexico reports 2,846 new coronavirus cases, 166 more deaths

Mexicos Health Ministry on Thursday reported 2,846 new confirmed coronavirus cases and 166 more deaths, bringing the total number of cases in the country to 2,358,831 and fatalities to 218,173.Separate government data published in March sug...

Nashik district records 4,160 COVID-19 cases, 49 deaths

The count of COVID-19 cases in Nashik district of Maharashtra rose to 3,46,251 with the addition of 4,160 new patients on Thursday, health department officials said.The virus claimed 49 more lives which took the death toll in the district t...

Why patents on COVID vaccines are so contentious

The Biden administrations call to lift patent protections on COVID-19 vaccines to help poor parts of the world get more doses has drawn praise from some countries and health advocates.But it has run into resistance from the pharmaceutical i...

Give Feedback